Impact of BRAF, MLH1 on the incidence of microsatellite instability high colorectal cancer in populations based study

Hassan Brim, Pooneh Mokarram, Fakhraddin Naghibalhossaini, Mehdi Saberi-Firoozi, Mansour Al-Mandhari, Kamla Al-Mawaly, Rayhaneh Al-Mjeni, Abeer Al-Sayegh, Sandy Raeburn, Edward Lee, Francis Giardiello, Duane T. Smoot, Alexander Vilkin, C. Richard Richard, Ajay Goel, Mitra Hafezi, Mehdi Nouraie, Hassan Ashktorab

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

We have identified an alternative pathway of tumorigenesis in sporadic colon cancer, involving microsatellite instability due to mismatched repair methylation, which may be driven by mutations in the BRAF gene (V600E). Colorectal cancer (CRC) is the most common cancer in the world, and African Americans show a higher incidence than other populations in the United States. We analyzed sporadic CRCs in Omani (of African origin, N = 61), Iranian (of Caucasian origin, N = 53) and African American (N = 95) patients for microsatellite instability, expression status of mismatched repair genes (hMLH1, hMSH2) and presence of the BRAF (V600E) mutation. In the Omani group, all tumors with BRAF mutations were located in the left side of the colon, and for African Americans, 88% 7 of tumors with BRAF mutations were found in the right side of the colon. In African Americans, 31% of tumors displayed microsatellite instability at two or more markers (MSI-H), while this rate was 26% and 13% for tumors in the Iranian and Omani groups, respectively. A majority of these MSI-H tumors were located in the proximal colon (right side) in African American and Iranian subjects, whereas most were located in the distal colon (left side) in Omani subjects. Defects in hMLH1 gene expression were found in 77% of MSI-H tumors in both African Americans and Iranians and in 38% of tumors in Omanis. BRAF mutations were observed in all subjects: 10% of tumors in African Americans (8/82), 2% of tumors in Iranians (1/53), and 19% of tumors in Omanis (11/59). Our findings suggest that CRC occurs at a younger age in Omani and Iranian patients, and these groups showed a lower occurrence of MSI-H than did African American patients. Our multivariate model suggests an important and significant role of hMLH1 expression and BRAF mutation in MSI-H CRC in these populations. The high occurrence of MSI-H tumors in African Americans may have significant implications for treatment, since patients with MSI-H lesions display a different response to chemotherapeutic agents such as 5-fluorouracil.

Original languageEnglish
Article number68
JournalMolecular Cancer
Volume7
DOIs
Publication statusPublished - Aug 21 2008

Fingerprint

Microsatellite Instability
Colorectal Neoplasms
African Americans
Incidence
Population
Neoplasms
Mutation
Colon
N-methylsuccinimide
Fluorouracil
Colonic Neoplasms
Methylation
Genes
Carcinogenesis

ASJC Scopus subject areas

  • Molecular Medicine
  • Oncology
  • Cancer Research

Cite this

Impact of BRAF, MLH1 on the incidence of microsatellite instability high colorectal cancer in populations based study. / Brim, Hassan; Mokarram, Pooneh; Naghibalhossaini, Fakhraddin; Saberi-Firoozi, Mehdi; Al-Mandhari, Mansour; Al-Mawaly, Kamla; Al-Mjeni, Rayhaneh; Al-Sayegh, Abeer; Raeburn, Sandy; Lee, Edward; Giardiello, Francis; Smoot, Duane T.; Vilkin, Alexander; Richard, C. Richard; Goel, Ajay; Hafezi, Mitra; Nouraie, Mehdi; Ashktorab, Hassan.

In: Molecular Cancer, Vol. 7, 68, 21.08.2008.

Research output: Contribution to journalArticle

Brim, H, Mokarram, P, Naghibalhossaini, F, Saberi-Firoozi, M, Al-Mandhari, M, Al-Mawaly, K, Al-Mjeni, R, Al-Sayegh, A, Raeburn, S, Lee, E, Giardiello, F, Smoot, DT, Vilkin, A, Richard, CR, Goel, A, Hafezi, M, Nouraie, M & Ashktorab, H 2008, 'Impact of BRAF, MLH1 on the incidence of microsatellite instability high colorectal cancer in populations based study', Molecular Cancer, vol. 7, 68. https://doi.org/10.1186/1476-4598-7-68
Brim, Hassan ; Mokarram, Pooneh ; Naghibalhossaini, Fakhraddin ; Saberi-Firoozi, Mehdi ; Al-Mandhari, Mansour ; Al-Mawaly, Kamla ; Al-Mjeni, Rayhaneh ; Al-Sayegh, Abeer ; Raeburn, Sandy ; Lee, Edward ; Giardiello, Francis ; Smoot, Duane T. ; Vilkin, Alexander ; Richard, C. Richard ; Goel, Ajay ; Hafezi, Mitra ; Nouraie, Mehdi ; Ashktorab, Hassan. / Impact of BRAF, MLH1 on the incidence of microsatellite instability high colorectal cancer in populations based study. In: Molecular Cancer. 2008 ; Vol. 7.
@article{b35a46f58d8d4d859a224b87c1d6a1ba,
title = "Impact of BRAF, MLH1 on the incidence of microsatellite instability high colorectal cancer in populations based study",
abstract = "We have identified an alternative pathway of tumorigenesis in sporadic colon cancer, involving microsatellite instability due to mismatched repair methylation, which may be driven by mutations in the BRAF gene (V600E). Colorectal cancer (CRC) is the most common cancer in the world, and African Americans show a higher incidence than other populations in the United States. We analyzed sporadic CRCs in Omani (of African origin, N = 61), Iranian (of Caucasian origin, N = 53) and African American (N = 95) patients for microsatellite instability, expression status of mismatched repair genes (hMLH1, hMSH2) and presence of the BRAF (V600E) mutation. In the Omani group, all tumors with BRAF mutations were located in the left side of the colon, and for African Americans, 88{\%} 7 of tumors with BRAF mutations were found in the right side of the colon. In African Americans, 31{\%} of tumors displayed microsatellite instability at two or more markers (MSI-H), while this rate was 26{\%} and 13{\%} for tumors in the Iranian and Omani groups, respectively. A majority of these MSI-H tumors were located in the proximal colon (right side) in African American and Iranian subjects, whereas most were located in the distal colon (left side) in Omani subjects. Defects in hMLH1 gene expression were found in 77{\%} of MSI-H tumors in both African Americans and Iranians and in 38{\%} of tumors in Omanis. BRAF mutations were observed in all subjects: 10{\%} of tumors in African Americans (8/82), 2{\%} of tumors in Iranians (1/53), and 19{\%} of tumors in Omanis (11/59). Our findings suggest that CRC occurs at a younger age in Omani and Iranian patients, and these groups showed a lower occurrence of MSI-H than did African American patients. Our multivariate model suggests an important and significant role of hMLH1 expression and BRAF mutation in MSI-H CRC in these populations. The high occurrence of MSI-H tumors in African Americans may have significant implications for treatment, since patients with MSI-H lesions display a different response to chemotherapeutic agents such as 5-fluorouracil.",
author = "Hassan Brim and Pooneh Mokarram and Fakhraddin Naghibalhossaini and Mehdi Saberi-Firoozi and Mansour Al-Mandhari and Kamla Al-Mawaly and Rayhaneh Al-Mjeni and Abeer Al-Sayegh and Sandy Raeburn and Edward Lee and Francis Giardiello and Smoot, {Duane T.} and Alexander Vilkin and Richard, {C. Richard} and Ajay Goel and Mitra Hafezi and Mehdi Nouraie and Hassan Ashktorab",
year = "2008",
month = "8",
day = "21",
doi = "10.1186/1476-4598-7-68",
language = "English",
volume = "7",
journal = "Molecular Cancer",
issn = "1476-4598",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Impact of BRAF, MLH1 on the incidence of microsatellite instability high colorectal cancer in populations based study

AU - Brim, Hassan

AU - Mokarram, Pooneh

AU - Naghibalhossaini, Fakhraddin

AU - Saberi-Firoozi, Mehdi

AU - Al-Mandhari, Mansour

AU - Al-Mawaly, Kamla

AU - Al-Mjeni, Rayhaneh

AU - Al-Sayegh, Abeer

AU - Raeburn, Sandy

AU - Lee, Edward

AU - Giardiello, Francis

AU - Smoot, Duane T.

AU - Vilkin, Alexander

AU - Richard, C. Richard

AU - Goel, Ajay

AU - Hafezi, Mitra

AU - Nouraie, Mehdi

AU - Ashktorab, Hassan

PY - 2008/8/21

Y1 - 2008/8/21

N2 - We have identified an alternative pathway of tumorigenesis in sporadic colon cancer, involving microsatellite instability due to mismatched repair methylation, which may be driven by mutations in the BRAF gene (V600E). Colorectal cancer (CRC) is the most common cancer in the world, and African Americans show a higher incidence than other populations in the United States. We analyzed sporadic CRCs in Omani (of African origin, N = 61), Iranian (of Caucasian origin, N = 53) and African American (N = 95) patients for microsatellite instability, expression status of mismatched repair genes (hMLH1, hMSH2) and presence of the BRAF (V600E) mutation. In the Omani group, all tumors with BRAF mutations were located in the left side of the colon, and for African Americans, 88% 7 of tumors with BRAF mutations were found in the right side of the colon. In African Americans, 31% of tumors displayed microsatellite instability at two or more markers (MSI-H), while this rate was 26% and 13% for tumors in the Iranian and Omani groups, respectively. A majority of these MSI-H tumors were located in the proximal colon (right side) in African American and Iranian subjects, whereas most were located in the distal colon (left side) in Omani subjects. Defects in hMLH1 gene expression were found in 77% of MSI-H tumors in both African Americans and Iranians and in 38% of tumors in Omanis. BRAF mutations were observed in all subjects: 10% of tumors in African Americans (8/82), 2% of tumors in Iranians (1/53), and 19% of tumors in Omanis (11/59). Our findings suggest that CRC occurs at a younger age in Omani and Iranian patients, and these groups showed a lower occurrence of MSI-H than did African American patients. Our multivariate model suggests an important and significant role of hMLH1 expression and BRAF mutation in MSI-H CRC in these populations. The high occurrence of MSI-H tumors in African Americans may have significant implications for treatment, since patients with MSI-H lesions display a different response to chemotherapeutic agents such as 5-fluorouracil.

AB - We have identified an alternative pathway of tumorigenesis in sporadic colon cancer, involving microsatellite instability due to mismatched repair methylation, which may be driven by mutations in the BRAF gene (V600E). Colorectal cancer (CRC) is the most common cancer in the world, and African Americans show a higher incidence than other populations in the United States. We analyzed sporadic CRCs in Omani (of African origin, N = 61), Iranian (of Caucasian origin, N = 53) and African American (N = 95) patients for microsatellite instability, expression status of mismatched repair genes (hMLH1, hMSH2) and presence of the BRAF (V600E) mutation. In the Omani group, all tumors with BRAF mutations were located in the left side of the colon, and for African Americans, 88% 7 of tumors with BRAF mutations were found in the right side of the colon. In African Americans, 31% of tumors displayed microsatellite instability at two or more markers (MSI-H), while this rate was 26% and 13% for tumors in the Iranian and Omani groups, respectively. A majority of these MSI-H tumors were located in the proximal colon (right side) in African American and Iranian subjects, whereas most were located in the distal colon (left side) in Omani subjects. Defects in hMLH1 gene expression were found in 77% of MSI-H tumors in both African Americans and Iranians and in 38% of tumors in Omanis. BRAF mutations were observed in all subjects: 10% of tumors in African Americans (8/82), 2% of tumors in Iranians (1/53), and 19% of tumors in Omanis (11/59). Our findings suggest that CRC occurs at a younger age in Omani and Iranian patients, and these groups showed a lower occurrence of MSI-H than did African American patients. Our multivariate model suggests an important and significant role of hMLH1 expression and BRAF mutation in MSI-H CRC in these populations. The high occurrence of MSI-H tumors in African Americans may have significant implications for treatment, since patients with MSI-H lesions display a different response to chemotherapeutic agents such as 5-fluorouracil.

UR - http://www.scopus.com/inward/record.url?scp=52949092457&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=52949092457&partnerID=8YFLogxK

U2 - 10.1186/1476-4598-7-68

DO - 10.1186/1476-4598-7-68

M3 - Article

C2 - 18718023

AN - SCOPUS:52949092457

VL - 7

JO - Molecular Cancer

JF - Molecular Cancer

SN - 1476-4598

M1 - 68

ER -